14 Our smaller number of dose reduction/switching cases ( n = 61) may have accounted for this subgroup only showing a nonsignificant trend for increased risk.
← all excerpts
Investigating the prevalence, predictors, and prognosis of suboptimal statin use early after a non-ST elevation acute coronary syndrome.
1
—
—